A Smoking Cessation Intervention for Severe Mental Ill Health Trial (SCIMITAR)

ISRCTN ISRCTN79497236
DOI https://doi.org/10.1186/ISRCTN79497236
Secondary identifying numbers HTA 07/41/05
Submission date
29/06/2009
Registration date
03/07/2009
Last edited
14/09/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Contact information

Prof Simon Gilbody
Scientific

Area 4, Seebohm Rowntree Building
Department of Health Sciences
University of York
Heslington
York
YO10 5DD
United Kingdom

Phone +44 (0)1904 321370
Email sg519@york.ac.uk

Study information

Study designPilot study and definitive fully randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)GP practice
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleA Smoking Cessation Intervention for Severe Mental Ill Health Trial: a pilot study and definitive randomised evaluation of a bespoke smoking cessation service
Study acronymSCIMITAR
Study hypothesis1. Bespoke smoking cessation service for people with severe mental ill health is more acceptable than usual GP care
2. Bespoke smoking cessation service for people with mental ill health is more clinically effective than usual GP care in facilitating smoking cessation
3. Bespoke smoking cessation service for people with mental ill health is more cost effective than usual GP care in facilitating smoking cessation
Ethics approval(s)Not provided at time of registration
ConditionTobacco addiction in severe mental illness
InterventionActive intervention: mental health nurse trained in smoking cessation counselling will work in conjunction with the patient and patients' GP or mental health specialist to provide a smoking cessation service individually tailored to each patient with mental ill health. This service will be in line with current National Institute for Clinical Excellence (NICE) guidelines for smoking cessation services and will include group support sessions for patients with mental ill health, pharmacotherapies to aid smoking cessation in addition to regular follow up by the smoking cessation officer.

Control intervention: GP or mental health specialist following current NICE guidelines for smoking cessation services. This may include pharmacotherapies to aid smoking cessation, access to self-help materials and referral to local NHS stop smoking clinics.

The total duration for the treatment and follow-up combined will be 12 months post-recruitment. This applies for both active and control intervention arms of the trial.
Intervention typeBehavioural
Primary outcome measureSmoking cessation measured at 12 months post-recruitment (validated using carbon monoxide measurements).
Secondary outcome measures1. Self reported smoking cessation at 4, 6 and 12 months
2. Health related quality of life (36-item short form health survey [SF-36])
3. Health-state utility (EQ5D) at 4, 6 and 12 months
Overall study start date01/06/2010
Overall study end date31/12/2012

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants100
Participant inclusion criteriaAdults of all ages (either sex) with severe and enduring mental illness who currently smoke.
Participant exclusion criteria1. Patients with alcohol dependence
2. Patients with co-morbid drug addiction
Recruitment start date01/06/2010
Recruitment end date31/12/2012

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

University of York
York
YO10 5DD
United Kingdom

Sponsor information

University of York (UK)
University/education

Heslington
York
YO10 5DD
England
United Kingdom

Phone +44 (0)1904 430000
Email mm714@york.ac.uk
Website http://www.york.ac.uk
ROR logo "ROR" https://ror.org/04m01e293

Funders

Funder type

Government

Health Technology Assessment Programme
Government organisation / National government
Alternative name(s)
NIHR Health Technology Assessment Programme, HTA
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/03/2015 Yes No
Results article results 01/05/2015 Yes No